Furthermore, He et al. demonstrated the potential of nuclear accumulation of the intracellular domain of EpCAM as a useful marker to distinguish aggressive papillary thyroid carcinoma from non-aggressive types [35]. Here, EPCAM is linked to differentiated thyroid carcinoma.